# KANEKA CORPORATION: business model and financials

> Latest period: FY ending Mar 2026, consolidated, J-GAAP
> Unit: JPY millions
> Sources: 有価証券報告書－第102期(2025/04/01－2026/03/31) (S100YIFD)
> Page: https://vizora.meequs.com/en/company/kaneka
> Retrieved: 2026-09-30T17:49:00.437Z

## Company

Kaneka, founded in 1949, is a company in Chemicals listed on TSE Prime. It has 11,762 employees (consolidated).

| Field | Value |
| --- | ---: |
| Legal name | KANEKA CORPORATION |
| Ticker | 4118 |
| Stock price | View on Yahoo Finance (https://finance.yahoo.co.jp/quote/4118.T) |
| Listing | TSE Prime |
| Head office | 大阪市北区中之島二丁目3番18号 |
| Representative (per filing) | 代表取締役社長 藤井一彦 |
| Founded | Sep 1949 |
| Share capital | ¥33B |
| Employees (consolidated) | 11,762 |
| Average salary (parent only) | ¥8.2M |
| Fiscal year end | March |
| Website | www.kaneka.co.jp (https://www.kaneka.co.jp/) |
| Corporate number | 8120001059628 |
| EDINET | E00879 |
| Industries (Vizora) | Chemicals, Textiles & Fibers, Medical Devices, Pharmaceuticals, Food Ingredients, Processed Foods |

> Profile source: annual securities report (S100YIFD, filed 2026-06-24). As of filing

## Five-axis industry profile

Primary industry: Chemicals (2026-03-31)

| Axis | Industry percentile | Peers |
| --- | ---: | ---: |
| Revenue growth | 65.1 | 96 |
| Profitability | 20.5 | 100 |
| Cash conversion | 50.5 | 96 |
| Efficiency | 77.5 | 100 |
| Financial strength | 39.5 | 19 |

Each axis is shown independently. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

## Key points (generated from figures)

- About 40% of Kaneka's sales come from Material Solutions Unit, with Nutrition Solutions Unit and Quality of Life Solutions Unit making up much of the rest.
- Out of every ¥100 of sales, about ¥4 is left as operating profit.
- Revenue changed +0.5% from the prior year, operating profit -17.9%.

## Company structure

- Segment revenue mix: Material Solutions Unit 40.3%、Nutrition Solutions Unit 25.4%、Quality of Life Solutions Unit 23.9%、Health Care Solutions Unit 10.2%、Other 0.1%
- Revenue → net income: ¥811638000000 → ¥32581000000
- Net income → operating cash flow: ¥32581000000 → ¥50118000000（difference ¥17537000000）
- Main uses of operating cash flow: CapEx ¥53382000000 / dividends ¥9321000000 / buybacks ¥12003000000
- Change in cash: ¥4303000000
Segment shares use total reported segment revenue, which may include inter-segment sales. The cash bridge is operating cash flow minus net income and combines non-cash items and working-capital effects.

## Key figures at a glance

| Metric | Value | Note |
| --- | ---: | ---: |
| Revenue | ¥811.6B |  |
| Operating income | ¥32.9B | Margin 4.1% |
| Net income | ¥31B | Margin 3.8% |
| Free cash flow | -¥3.26B |  |
| Largest business | Material Solutions Unit | of segment revenue 40.3% |
| Employees (consolidated) | 11,762 |  |
| EPS | ¥369.65 |  |
| Diluted EPS | ¥368.33 |  |
| Book value per share | ¥4999.31 |  |
| Equity ratio | 52.0% |  |
| Shares outstanding | 63,000,000 |  |
| Treasury shares | 2,780,600 |  |
| Shareholders | 21,632 |  |
| Average salary (parent only) | ¥8.2M | Filing company only |
| Cash ratio | 5.1% | Net cash -¥164.6B · Cash ÷ revenue 6.0% |
| Vs. industry median margin | -3.5 pp | Chemicals |
| ROE | 7.6% | Derived from disclosed figures |
| ROA | 3.3% | Derived from disclosed figures |

## Notable figures

- FY2026, buybacks were 1.3× dividends

## What changed in 5 years

| Metric | FY ending Mar 2021 | FY ending Mar 2026 | Change |
| --- | ---: | ---: | ---: |
| Revenue | ¥577426000000 | ¥811638000000 | +40.6% |
| Operating income | ¥27544000000 | ¥32894000000 | +19.4% |
| Operating margin | 4.8% | 4.1% | -0.7 pp |
| Employees | 11,272 people | 11,762 people | +4.3% |
| Cash and equivalents | ¥46360000000 | ¥48935000000 | +5.6% |

### Change in segment revenue mix

Span: FY ending Mar 2021 → FY ending Mar 2026. Stable segment keys are connected; unmatched shares are marked as new or reorganized. Shares use total segment revenue.

| Flow | Revenue share |
| --- | ---: |
| Material Solutions Unit → Material Solutions Unit | 39.9% |
| Quality of Life Solutions Unit → Quality of Life Solutions Unit | 23.9% |
| Quality of Life Solutions Unit → 事業再編・廃止 | 0.5% |
| Health Care Solutions Unit → Health Care Solutions Unit | 9.1% |
| Nutrition Solutions Unit → Nutrition Solutions Unit | 25.4% |
| Nutrition Solutions Unit → 事業再編・廃止 | 1.0% |
| その他 → その他 | 0.1% |
| その他 → 事業再編・廃止 | 0.1% |
| 新設・再編 → Material Solutions Unit | 0.4% |
| 新設・再編 → Health Care Solutions Unit | 1.1% |

Segment revenue source references: 10 (derived)

## Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: latest revenue. CAGR requires at least two comparable years.

| Segment | CAGR span | Revenue CAGR | Latest revenue | Operating margin | Source refs |
| --- | ---: | ---: | ---: | ---: | ---: |
| Material Solutions Unit | 5 years | +7.3% | ¥327235000000 | 7.6% | 2 |
| Nutrition Solutions Unit | 5 years | +6.2% | ¥205977000000 | 6.7% | 2 |
| Quality of Life Solutions Unit | 5 years | +6.6% | ¥194340000000 | 9.2% | 2 |
| Health Care Solutions Unit | 5 years | +9.6% | ¥82975000000 | 17.9% | 2 |
| Other | 5 years | -0.7% | ¥1109000000 | 49.7% | 2 |

## Income statement（FY ending Mar 2026, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Revenue | 811,638 | 100.0% | S100YIFD |
| Cost of revenue | 586,088 | 72.2% | S100YIFD |
| Gross profit | 225,550 | 27.8% | S100YIFD |
| SG&A | 192,655 | 23.7% | S100YIFD |
| Operating income | 32,894 | 4.1% | S100YIFD |
| Ordinary income | 28,873 | 3.6% | S100YIFD |
| Pretax income | 44,760 | 5.5% | S100YIFD |
| Income tax | 12,179 | 1.5% | S100YIFD |
| Net income | 32,581 | 4.0% | S100YIFD |
| Net income attributable to owners | 30,977 | 3.8% | S100YIFD |

## Per ¥100 of revenue（FY ending Mar 2026）

| Part | JPY |
| --- | ---: |
| Cost of revenue | 72 |
| SG&A | 24 |
| Operating income | 4 |
| (Ref.) Net income | 4 |

### Margin funnel

Gross margin 27.8% → Operating margin 4.1% → Net margin 3.8%
Derived from reported figures (DERIVED).

## Revenue and profit pattern

Pattern: Revenue up, profit down
Revenue growth: +0.5%; Core profit growth: -17.9%
Growth quality: revenue-led
Operating leverage (core profit growth ÷ revenue growth): -32.50×
Calculated from comparable annual consolidated filings.

## Year over year（FY ending Mar 2025 → FY ending Mar 2026、JPY mn）

| Metric | Prior | Current | Change | % change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 807,200 | 811,638 | 4,438 | +0.5% |
| Gross profit | 225,644 | 225,550 | -94 | -0.0% |
| Operating income | 40,050 | 32,894 | -7,156 | -17.9% |
| Net income attributable to owners | 25,309 | 30,977 | 5,668 | +22.4% |
| Operating cash flow | 41,252 | 50,118 | 8,866 | +21.5% |
| Free cash flow | -14,729 | -3,264 | 11,465 | — |

## History（JPY mn）

| Period | Revenue | Op. income | Op. margin | Net income | Op. CF | FCF | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FY ending Mar 2020 | 601,514 | 26,014 | 4.3% | 14,003 | 39,983 | -6,291 | S100LKT6 |
| FY ending Mar 2021 | 577,426 | 27,544 | 4.8% | 15,831 | 74,040 | 31,644 | S100OK44 |
| FY ending Mar 2022 | 691,530 | 43,562 | 6.3% | 26,487 | 34,106 | -5,824 | S100R8UA |
| FY ending Mar 2023 | 755,821 | 35,087 | 4.6% | 23,008 | 28,710 | -13,281 | S100TV9M |
| FY ending Mar 2024 | 762,302 | 32,579 | 4.3% | 23,220 | 61,911 | -3,355 | S100W4R9 |
| FY ending Mar 2025 | 807,200 | 40,050 | 5.0% | 25,309 | 41,252 | -14,729 | S100YIFD |
| FY ending Mar 2026 | 811,638 | 32,894 | 4.1% | 30,977 | 50,118 | -3,264 | S100YIFD |

## People and productivity（FY ending Mar 2026, consolidated, J-GAAP）

| Metric | Value |
| --- | ---: |
| Revenue per employee (consolidated) | ¥69M |
| Operating income per employee (consolidated) | ¥2.8M |
| Net income per employee (consolidated) | ¥2.6M |

Employees, revenue and profit are consolidated. Average annual salary is a separate parent-company figure. Calculated from disclosed figures (DERIVED).

| History | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Employees (consolidated) | 11,335 | 11,545 | 11,544 | 11,512 | 11,762 |
| Average salary (parent company) | ¥7.6M | ¥7.7M | ¥8M | ¥8.1M | ¥8.2M |
| Average age (parent company) | 41.0 years | 41.0 years | 41.0 years | 41.0 years | 41.0 years |
| Average tenure (parent company) | 17.0 years | 17.0 years | 17.0 years | 17.0 years | 16.0 years |

Year over year: Employees (consolidated) +2.2% · Revenue (consolidated) +0.5%

## Segments（FY ending Mar 2026, consolidated, J-GAAP、JPY mn）

| Segment | Revenue | Share | Op. income | Op. margin |
| --- | ---: | ---: | ---: | ---: |
| Material Solutions Unit | 327,235 | 40.3% | 24,928 | 7.6% |
| Quality of Life Solutions Unit | 194,340 | 23.9% | 17,954 | 9.2% |
| Health Care Solutions Unit | 82,975 | 10.2% | 14,840 | 17.9% |
| Nutrition Solutions Unit | 205,977 | 25.4% | 13,712 | 6.7% |
| Other | 1,109 | 0.1% | 551 | 49.7% |

### segmentMix — Revenue and profit mix

Calculated from disclosed figures (DERIVED). Shares use total segment revenue and total positive segment profit respectively. Difference = profit share − revenue share (pt). Inter-segment sales may prevent reconciliation to company revenue.

| Segment | Revenue share | Profit share | Difference (pt) | Margin |
| --- | ---: | ---: | ---: | ---: |
| Material Solutions Unit | 40.3% | 34.6% | -5.7 | 7.6% |
| Quality of Life Solutions Unit | 23.9% | 24.9% | 1.0 | 9.2% |
| Health Care Solutions Unit | 10.2% | 20.6% | 10.4 | 17.9% |
| Nutrition Solutions Unit | 25.4% | 19.0% | -6.3 | 6.7% |
| Other | 0.1% | 0.8% | 0.6 | 49.7% |

Segment → industry: Material Solutions Unit → Chemicals / Quality of Life Solutions Unit → Chemicals / Quality of Life Solutions Unit → Textiles & Fibers / Health Care Solutions Unit → Medical Devices / Health Care Solutions Unit → Pharmaceuticals / Nutrition Solutions Unit → Food Ingredients / Nutrition Solutions Unit → Processed Foods

## Revenue by geography

No geographic revenue breakdown was disclosed.

## Cash flow（FY ending Mar 2026, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Operating cash flow | 50,118 | 6.2% | S100YIFD |
| Capital expenditure | 53,382 | 6.6% | S100YIFD |
| Free cash flow | -3,264 | -0.4% | 算出 |
| Investing cash flow | -26,097 | -3.2% | S100YIFD |
| Financing cash flow | -19,988 | -2.5% | S100YIFD |
| Dividends paid | 9,321 | 1.1% | S100YIFD |
| Share buyback | 12,003 | 1.5% | S100YIFD |
| Change in cash | 4,303 | 0.5% | S100YIFD |
| Cash and equivalents | 48,935 | 6.0% | S100YIFD |

## Balance sheet

Figures are as of each fiscal year end. Derived values are marked as such in the source column. Lease liabilities are excluded from interest-bearing debt.

| Metric | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | 40,712 | 40,699 | 43,278 | 44,631 | 48,935 | S100TV9M, S100W4R9, S100YIFD |
| Total assets | 726,959 | 782,640 | 870,205 | 920,143 | 959,154 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Net assets | 412,204 | 436,422 | 474,383 | 492,419 | 521,669 | S100TV9M, S100W4R9, S100YIFD |
| Share capital | 33,046 | 33,046 | 33,046 | 33,046 | 33,046 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Property, plant and equipment | 271,275 | 292,615 | 331,319 | 340,435 | 355,780 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Intangible assets excluding goodwill | 14,977 | 16,189 | 20,832 | 33,159 | 33,163 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Goodwill | 2,559 | 2,201 | 1,859 | 2,671 | 2,213 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Investment securities | 58,609 | 57,422 | 70,150 | 61,184 | 52,139 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Current assets | 362,910 | 396,964 | 428,861 | 444,524 | 465,718 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Current liabilities | 234,502 | 258,242 | 291,666 | 294,933 | 304,056 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Trade payables | 92,068 | 88,663 | 104,212 | 86,876 | 81,006 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Short-term borrowings | 89,992 | 116,491 | 116,532 | 132,511 | 139,531 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Long-term borrowings | 28,627 | 33,706 | 40,391 | 57,972 | 59,045 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Bonds | 10,000 | 10,000 | 15,000 | 15,000 | 15,000 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Interest-bearing debt | 128,619 | 160,197 | 171,923 | 205,483 | 213,576 | 算出 |
| Total liabilities | 314,755 | 346,217 | 395,822 | 427,724 | 437,485 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Non-controlling interests | 24,435 | 18,427 | 20,271 | 20,482 | 22,241 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Equity attributable to owners of parent | 362,417 | 377,098 | 387,355 | 401,118 | 410,986 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Retained earnings | 309,507 | 323,213 | 331,933 | 349,925 | 359,255 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |
| Treasury stock | -11,528 | -11,407 | -6,797 | -11,725 | -11,400 | S100R8UA, S100TV9M, S100W4R9, S100YIFD |

### Assets and funding mix

| Assets | Share | Source |
| --- | ---: | ---: |
| Cash | 5% | S100YIFD |
| Property, plant and equipment | 37% | S100YIFD |
| Intangibles and goodwill | 4% | S100YIFD |
| Investment securities | 5% | S100YIFD |
| Other assets | 49% | S100YIFD |

| Funding source | Share | Source |
| --- | ---: | ---: |
| Trade payables | 9% | S100YIFD |
| Interest-bearing debt | 22% | 算出 |
| Other liabilities | 15% | S100YIFD |
| Equity | 54% | S100YIFD |

### Balance sheet history

| Metric | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Total assets | 726,959 | 782,640 | 870,205 | 920,143 | 959,154 |
| Equity | 412,204 | 436,422 | 474,383 | 492,419 | 521,669 |
| Interest-bearing debt | 128,619 | 160,197 | 171,923 | 205,483 | 213,576 |
| Cash | 40,712 | 40,699 | 43,278 | 44,631 | 48,935 |

## Asset intensity and goodwill

Ratios are derived from reported values. Goodwill is used only when separately reported, never inferred from combined intangible assets.

| Metric | Value | Sources |
| --- | ---: | ---: |
| Asset intensity (fixed assets ÷ revenue) | 43.8% | S100YIFD |
| Fixed assets ÷ total assets | 37.1% | S100YIFD |
| Goodwill ÷ parent equity | 0.5% | S100YIFD |

Goodwill over 4 years: 2,559 → 2,213 JPY; total investing cash flow: -221,471 JPY. This does not imply causation.

### Cash quality

Net cash = cash − interest-bearing debt. Net debt ratio = (interest-bearing debt − cash) ÷ positive operating cash flow. Omit when debt components are incomplete; other ratios are derived from reported figures.

| Metric | Value |
| --- | ---: |
| Cash ratio (cash ÷ total assets) | 5.1% |
| Cash ÷ revenue | 6.0% |
| Net cash (cash − interest-bearing debt) | -¥164.6B |
| Net debt ÷ operating cash flow | 3.29× |
| Cash conversion (operating CF ÷ operating income) | 152.4% |
| Cash vs. profit gap | 19,141 JPY mn (of net income 61.8%) |
| Shareholder returns / net income | 68.8% |
| Shareholder returns / FCF | — |
| Shareholder payments — dividends / net income | 30.1% |
| Shareholder payments — dividends / FCF | — |
| CapEx intensity (capex ÷ revenue) | 6.6% |
| Investing CF relative to operating CF | 52.1% |

## ROA and ROE

ROE is decomposed into net margin × asset turnover × financial leverage. Leverage can raise ROE, so the ratio alone does not assess a company's condition. Ending balances are used without a prior year; total equity approximates parent equity when unavailable.

| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE | Sources |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| 2022 | 3.8% | 0.95× | 3.6% | 2.01× | 7.3% | S100R8UA |
| 2023 | 3.0% | 1.00× | 3.0% | 2.04× | 6.2% | S100TV9M |
| 2024 | 3.0% | 0.92× | 2.8% | 2.16× | 6.1% | S100W4R9 |
| 2025 | 3.1% | 0.90× | 2.8% | 2.27× | 6.4% | S100YIFD |
| 2026 | 3.8% | 0.86× | 3.3% | 2.31× | 7.6% | S100YIFD |

## Ownership

| Counterparty | Relation | Ratio | As of |
| --- | ---: | ---: | ---: |
| 日本マスタートラスト信託銀行株式会社（信託口） | Major shareholder | 11.3% | 2026-03-31 |
| 日本生命保険相互会社（常任代理人 日本マスタートラスト信託銀行株式会社） | Major shareholder | 5.2% | 2026-03-31 |
| 株式会社三井住友銀行 | Major shareholder | 4.9% | 2026-03-31 |
| 明治安田生命保険相互会社（常任代理人 株式会社日本カストディ銀行） | Major shareholder | 4.7% | 2026-03-31 |
| 株式会社三菱ＵＦＪ銀行 | Major shareholder | 3.6% | 2026-03-31 |
| 三井住友海上火災保険株式会社 | Major shareholder | 3.5% | 2026-03-31 |
| 株式会社日本カストディ銀行（信託口） | Major shareholder | 3.4% | 2026-03-31 |
| カネカ取引先持株会 | Major shareholder | 2.4% | 2026-03-31 |
| ＳＴＡＴＥ ＳＴＲＥＥＴ ＢＡＮＫ ＡＮＤ ＴＲＵＳＴ ＣＯＭＰＡＮＹ ５０５２２３（常任代理人 株式会社みずほ銀行） | Major shareholder | 2.4% | 2026-03-31 |
| カネカ従業員持株会 | Major shareholder | 2.2% | 2026-03-31 |

## AI commentary（text by AI; the tables above are authoritative、claude-code）

- Revenue for the FY ending Mar 2026 was ¥811.6B, up +0.5% from ¥807.2B, so roughly flat.
- Operating income dropped from ¥40B to ¥32.9B (-17.9%), as profits shrank in the materials and quality-of-life units.
- Net income attributable to owners still grew from ¥25.3B to ¥31B (+22.4%).
- Operating cash flow rose to ¥50.1B but did not cover ¥53.4B of capital spending, so free cash flow was -¥3.26B.

### Drivers

- The materials unit sold and earned less, hit by weak Asian markets and soft US housing and construction demand
- The quality-of-life unit grew sales, but higher raw material costs cut its profit
- Health care grew on sales of blood purification devices and catheters, and nutrition grew on supplement ingredients and price increases; both raised sales and profit

### Risks

- Conflict in the Middle East is pushing up oil and naphtha prices and raising supply worries, with a risk of a global slowdown
- Many raw materials and fuels are priced on world markets, so unexpected price swings can hurt results
- With a large overseas business, sudden currency moves or changes in foreign rules and taxes could affect earnings

Cited: Annual Securities Report (102nd term) (MD&A); Annual Securities Report (102nd term) (Business risks)

## Sources

| Document | ID | Published | URL |
| --- | ---: | ---: | ---: |
| 有価証券報告書－第102期(2025/04/01－2026/03/31) | S100YIFD | 2026-06-24 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YIFD,, |
| 有価証券報告書－第101期(2024/04/01－2025/03/31) | S100W4R9 | 2025-06-26 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100W4R9,, |
| 有価証券報告書－第100期(2023/04/01－2024/03/31) | S100TV9M | 2024-06-27 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100TV9M,, |
| 有価証券報告書－第99期(2022/04/01－2023/03/31) | S100R8UA | 2023-06-29 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100R8UA,, |
| 有価証券報告書－第98期(令和3年4月1日－令和4年3月31日) | S100OK44 | 2022-06-29 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100OK44,, |
| 有価証券報告書－第97期(令和2年4月1日－令和3年3月31日) | S100LKT6 | 2021-06-25 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100LKT6,, |

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).